(Q28210110)

English

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

scientific article (publication date: March 2001)

Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats (English)

0 references

Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Micaela Morelli

object named as

Micaela Morelli

3

1 reference

ORCID Public Data File 2021

author name string

A Pinna

1

0 references

S Fenu

2

0 references

M Morelli

3

0 references

Annalisa Pinna

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sandro Fenu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

233-8

0 references

233-238

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

The pharmacology of Parkinson's disease therapy: an update

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Potential role of adenosine antagonist therapy in pathological tremor disorders

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Adenosine receptor subtypes: characterization and therapeutic regulation

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Caffeine and the antiparkinsonian response to levodopa or piribedil

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010301%2939%3A3%3C233%3A%3AAID-SYN1004%3E3.0.CO%3B2-K

21 January 2018

Identifiers

10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K

0 references

PubMed publication ID

0 references

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11169767%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28210110&oldid=1589189309"